Allie Greenplate
Graduate Student (M&I)
Last active: 4/25/2016

Allie Greenplate, B.S.

Official Affiliation: Pathology, Microbiology & Immunology

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti-PD-1 Therapy. Greenplate AR, Johnson DB, Roussel M, Savona MR, Sosman JA, Puzanov I, Ferrell PB, Irish JM (2016) Cancer Immunol Res 4(6): 474-480
    › Primary publication · 26966176 (PubMed) · PMC4891280 (PubMed Central)
  2. A peptide immunization approach to counteract a Staphylococcus aureus protease defense against host immunity. Jordan RE, Fernandez J, Brezski RJ, Greenplate AR, Knight DM, Raju TS, Lynch AS (2016) Immunol Lett : 29-39
    › Primary publication · 26905931 (PubMed)
  3. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy. Johnson DB, Estrada MV, Salgado R, Sanchez V, Doxie DB, Opalenik SR, Vilgelm AE, Feld E, Johnson AS, Greenplate AR, Sanders ME, Lovly CM, Frederick DT, Kelley MC, Richmond A, Irish JM, Shyr Y, Sullivan RJ, Puzanov I, Sosman JA, Balko JM (2016) Nat Commun : 10582
    › Primary publication · 26822383 (PubMed) · PMC4740184 (PubMed Central)
  4. Multiparameter analysis of stimulated human peripheral blood mononuclear cells: A comparison of mass and fluorescence cytometry. Nicholas KJ, Greenplate AR, Flaherty DK, Matlock BK, Juan JS, Smith RM, Irish JM, Kalams SA (2016) Cytometry A 89(3): 271-80
    › Primary publication · 26599989 (PubMed) · PMC4808335 (PubMed Central)
  5. Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease. Biancheri P, Brezski RJ, Di Sabatino A, Greenplate AR, Soring KL, Corazza GR, Kok KB, Rovedatti L, Vossenkämper A, Ahmad N, Snoek SA, Vermeire S, Rutgeerts P, Jordan RE, MacDonald TT (2015) Gastroenterology 149(6): 1564-1574.e3
    › Primary publication · 26170138 (PubMed)
  6. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions. Kinder M, Greenplate AR, Strohl WR, Jordan RE, Brezski RJ (2015) MAbs 7(3): 494-504
    › Primary publication · 25933349 (PubMed) · PMC4622058 (PubMed Central)
  7. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo. Brezski RJ, Kinder M, Grugan KD, Soring KL, Carton J, Greenplate AR, Petley T, Capaldi D, Brosnan K, Emmell E, Watson S, Jordan RE (2014) MAbs 6(5): 1265-73
    › Primary publication · 25517311 (PubMed) · PMC4623506 (PubMed Central)
  8. Engineered protease-resistant antibodies with selectable cell-killing functions. Kinder M, Greenplate AR, Grugan KD, Soring KL, Heeringa KA, McCarthy SG, Bannish G, Perpetua M, Lynch F, Jordan RE, Strohl WR, Brezski RJ (2013) J Biol Chem 288(43): 30843-54
    › Primary publication · 23986451 (PubMed) · PMC3829399 (PubMed Central)
  9. Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function. Grugan KD, McCabe FL, Kinder M, Greenplate AR, Harman BC, Ekert JE, van Rooijen N, Anderson GM, Nemeth JA, Strohl WR, Jordan RE, Brezski RJ (2012) J Immunol 189(11): 5457-66
    › Primary publication · 23105143 (PubMed)
  10. A single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacy. Fan X, Brezski RJ, Fa M, Deng H, Oberholtzer A, Gonzalez A, Dubinsky WP, Strohl WR, Jordan RE, Zhang N, An Z (2012) Breast Cancer Res 14(4): R116
    › Primary publication · 22873525 (PubMed) · PMC3680949 (PubMed Central)
  11. The in vitro resistance of IgG2 to proteolytic attack concurs with a comparative paucity of autoantibodies against peptide analogs of the IgG2 hinge. Brezski RJ, Oberholtzer A, Strake B, Jordan RE (2011) MAbs 3(6): 558-67
    › Primary publication · 22123056 (PubMed) · PMC3242842 (PubMed Central)
  12. Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge. Brezski RJ, Vafa O, Petrone D, Tam SH, Powers G, Ryan MH, Luongo JL, Oberholtzer A, Knight DM, Jordan RE (2009) Proc Natl Acad Sci U S A 106(42): 17864-9
    › Primary publication · 19815504 (PubMed) · PMC2758810 (PubMed Central)

Featured Affiliation

View all affiliations

Contact Information

2220 Pierce Avenue
742 Preston Research Building
Nashville, TN 37232
USA
615 (p)
875-0965 (f)
Email

Keywords & MeSH Terms

MeSH terms are retrieved from PubMed records. Learn more.

Key: MeSH Term Keyword

Aged Amino Acid Sequence Antibodies Antibodies, Monoclonal, Humanized Antigens, CD Bacterial Load Biological Factors Blocking CD11b Antigen Cell Proliferation Cytokines Disease Progression Epitopes Flow Cytometry Gene Expression Genes, MHC Class II Immunoglobulin Fc Fragments Immunology Immunophenotyping Immunotherapy immunotherapy of cancer and biomarkers Inflammatory Bowel Diseases In Vitro Techniques Male Mass Cytometry Melanoma Mice, Inbred C57BL Mice, SCID Molecular Sequence Data Neoplasm Invasiveness Peptide Fragments Peptides Phagocytosis Phospho-Flow Cytometry Platelet Count Serine Endopeptidases Staphylococcal Infections Streptococcus pyogenes Trastuzumab Tumor Immunology